Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update describes hypofractionated radiotherapy with a focal microboost for high-risk and locally advanced prostate cancer. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of South Carolina | Conditions: Prostate Cancer, Prostate Cancer Patients Treated by Radiotherapy | Phase 2 | Status: RECRUITING